Makoto Kawai

USPTO Granted Patents = 13 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 5)

Average Co-Inventor Count = 2.4

ph-index = 7

Forward Citations = 110(Granted Patents)

Location History:

Toyonaka, JP (2015)
Osaka, JP (2014 - 2022)

Company Filing History:

13 out of 1,001

Shionogi Company Limited

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12098151 - Arenavirus growth inhibitor comprising polycyclic carbamoyl pyridone derivative (2024-09-24),

2. 11492352 - Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative (2022-11-08),

3. 11306106 - Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof (2022-04-19),

4. 10759814 - Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof (2020-09-01),

5. 10633397 - Substituted polycyclic pyridone derivatives and prodrugs thereof (2020-04-28),

6. 10392406 - Substituted polycyclic pyridone derivatives and prodrugs thereof (2019-08-27),

7. 10202379 - Substituted polycyclic carbamoyl pyridone derivative prodrug (2019-02-12),

8. 9815835 - Substituted polycyclic carbamolypyridone derivative (2017-11-14),

9. 9758515 - Substituted polycyclic carbamoyl pyridone derivative prodrug (2017-09-12),

10. 9469638 - Substituted polycyclic carbamoylpyridone derivative (2016-10-18),

11. 8987441 - Substituted polycyclic carbamoyl pyridone derivative prodrug (2015-03-24),

12. 8927710 - Substituted polycyclic carbamoylpyridone derivative (2015-01-06),

13. 8835461 - Substituted 3-hydroxy-4-pyridone derivative (2014-09-16),

Title: The Innovative Contributions of Makoto Kawai

Introduction

Makoto Kawai is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of antiviral research, particularly focusing on arenavirus proliferation inhibitors. With a total of 13 patents to his name, Kawai's work has the potential to impact public health positively.

Latest Patents

Kawai's latest patents include an arenavirus growth inhibitor comprising a polycyclic carbamoyl pyridone derivative. This invention provides a compound with antiviral activity, specifically targeting arenavirus proliferation. The compound is designed to inhibit the growth of both Old World arenaviruses, such as the Lassa virus and lymphocytic choriomeningitis virus, and New World arenaviruses, including the Junin virus. The patent details a compound represented by a specific formula, which includes various chemical components that enhance its efficacy as a medicament.

Career Highlights

Throughout his career, Makoto Kawai has worked with notable organizations, including Shionogi & Company Limited and Hokkaido University. His experience in these institutions has allowed him to develop innovative solutions in the field of virology and pharmaceuticals.

Collaborations

Kawai has collaborated with esteemed colleagues, including Yoshiyuki Taoda and Toshiyuki Akiyama. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Makoto Kawai's contributions to antiviral research and his innovative patents demonstrate his commitment to improving public health. His work continues to pave the way for new treatments against viral infections.

This text is generated by artificial intelligence and may not be accurate.